LMDXW
Price:
$0.0041
Market Cap:
$5.10M
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
Industry
Medical - Diagnostics & Research
IPO Date
2021-09-29
Stock Exchange
NASDAQ
Ticker
LMDXW
According to LumiraDx Limited’s latest financial reports and current stock price. The company's current ROE is -1557.76%. This represents a change of 858.68% compared to the average of -162.49% of the last 4 quarters.
The mean historical ROE of LumiraDx Limited over the last ten years is 129.23%. The current -1557.76% ROE has changed -1305.38% with respect to the historical average. Over the past ten years (40 quarters), LMDXW's ROE was at its highest in in the December 2022 quarter at 91.38%. The ROE was at its lowest in in the June 2022 quarter at -932.24%.
Average
129.23%
Median
75.74%
Minimum
-61.90%
Maximum
427.37%
Discovering the peaks and valleys of LumiraDx Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 427.37%
Minimum Annual Increase = -790.39%
Minimum Annual ROE = -61.90%
Year | ROE | Change |
---|---|---|
2022 | 427.37% | -790.39% |
2021 | -61.90% | -196.32% |
2020 | 64.26% | -26.31% |
The current ROE of LumiraDx Limited (LMDXW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
143.24%
5-year avg
129.23%
10-year avg
129.23%
LumiraDx Limited’s ROE is greater than LumiraDx Limited (-1557.76%), less than Roivant Sciences Ltd. (-3.29%), less than Jasper Therapeutics, Inc. (19.07%), greater than SomaLogic, Inc. (-18.59%), greater than Procaps Group, S.A. (-221.90%),
Company | ROE | Market cap |
---|---|---|
-1557.76% | $5.10M | |
-3.29% | $7.83B | |
19.07% | $1.50M | |
-18.59% | $396.23M | |
-221.90% | $1.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LumiraDx Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LumiraDx Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LumiraDx Limited's ROE?
How is the ROE calculated for LumiraDx Limited (LMDXW)?
What is the highest ROE for LumiraDx Limited (LMDXW)?
What is the 3-year average ROE for LumiraDx Limited (LMDXW)?
What is the 5-year average ROE for LumiraDx Limited (LMDXW)?
How does the current ROE for LumiraDx Limited (LMDXW) compare to its historical average?